AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:07 14/06/2024 BST			5-day change	1st Jan Change
12,510 ^GBX	+0.95%		-0.37%	+18.02%

06-14	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	MT
06-13	Tesla, Inc. : Musk moves a step closer to the $56 billion prize and the transfer of Tesla's headquarters to Texas

Indonesia To Receive Between 13.7 To 23.1 Million Doses Of Astrazeneca Vaccine Through Covax Alliance Scheme - Foreign Ministry

January 31, 2021 at 12:05 pm

INDONESIA TO RECEIVE BETWEEN 13.7 TO 23.1 MILLION DOSES OF ASTRAZENECA VACCINE THROUGH COVAX ALLIANCE SCHEME - FOREIGN MINISTRY

Latest news about AstraZeneca PLC

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	06-14	MT
Tesla, Inc. : Musk moves a step closer to the $56 billion prize and the transfer of Tesla's headquarters to Texas	06-13
AstraZeneca: Farxiga approved for diabetes as of age 10	06-13	CF
AstraZeneca's Type-2 Diabetes Drug Wins Pediatric Approval in US	06-13	MT
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.	06-12	DJ
AstraZeneca Gets FDA Approval for Pediatric Type-2 Diabetes Control Drug	06-12	MT
AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes	06-12	AN
European Equities Close Lower in Monday Trading Following Far Right Gains in EU Elections	06-10	MT
UK Stocks Join Europe Retreat Ahead of US Fed Rate Decision	06-10	MT
ASTRAZENECA : Berenberg raises its price target	06-10	CF
AstraZeneca shares outperform, Berenberg raises target	06-10	CF
Berenberg Raises AstraZeneca PT, Maintains Buy Rating	06-10	MT
AstraZeneca's Tagrisso Secures Priority Review in the US	06-10	MT
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating	06-10	MT
JPMorgan cuts Aviva but lifts M&G	06-10	AN
Investors remain cautious as political instability takes over Europe	06-10
AstraZeneca: priority review in the USA for Tagrisso	06-10	CF
Astra's Tagrisso gets US priority review for lung cancer	06-10	AN
FTSE called down amid political uncertainty in EU	06-10	AN
AstraZeneca Wins US FDA's Priority Review Tag for Expanded Use of Lung Cancer Drug	06-10	MT
ASTRAZENECA : Berenberg gives a Buy rating	06-10	ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating	06-07	ZD
Department of Health - Abu Dhabi and AstraZeneca Expand Partnership During Bio International Convention 2024 to Establish New Rare Diseases Centre of Excellence	06-05	CI
HSBC Raises AstraZeneca PT, Keeps Buy Rating	06-05	MT
ASTRAZENECA : Deutsche Bank remains Neutral	06-05	ZD

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

25/07/2024 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 05:02 pm

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

158.6 USD

Average target price

174.4 USD

Spread / Average Target

+9.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+18.02%	246B
ELI LILLY AND COMPANY	+50.70%	791B
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B

Other Pharmaceuticals

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Indonesia To Receive Between 13.7 To 23.1 Million Doses Of Astrazeneca Vaccine Through Covax Alliance Scheme - Foreign Ministry

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals